AlphaVax, Inc.
AlphaVax, Inc. company was founded in 1998 by Robert Johnston, Nancy Davis, and Jonathan Smith, AlphaVax's chief scientific officer. AlphaVax, Inc. company is developing new vaccines for cancers and infectious diseases such as HIV/AIDS, Ebola, influenza, and other viral maladies. AlphaVax relies on a proprietary alphavaccine system that genetically alters diseased cells and transforms them into a vaccine when they attempt to replicate. Its technology could be used to develop preventative vaccines and therapeutic vaccines. Its pipeline consists of early-stage candidates. AlphaVax receives funding through partnerships and grants.
Contact Details
Office Address
AlphaVax, Inc.
2 Triangle Drive
Research Triangle Park, NC, USA 27709-0307
Phone: (919) 595-0400
Fax: (919) 595-0401
Executives
Chairman
Jonathan Gelles
Chief Scientific Officer
Jonathan F. Smith